Company / Profit Margin
Xeris Biopharma Holdings, Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
0.2%
FY2025
5-year range
-247.5% / 0.2%
FY2021-FY2025
Trend
+100.7%
vs FY2024
Sector context
#57 of 146
Health Care
What the data says
At 0.2%, Xeris Biopharma Holdings, Inc.'s profit margin ranks #57 of 146 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -247.5% in FY2022 to 0.2% in FY2025.
Based on SEC 10-K filings.
0.2% in FY2025 with a 3-year CAGR of +247.7%.
Improved from -38.0% to 0.2% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +247.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#57 of 146 in Health CareTop 39% of 146This company 0.2% Sector average -796.3%
▼
+100.0% above sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 100.7% year-over-year.
- Currently 796.5pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 0.2% | +100.7% |
| FY2024 | -27.0% | +28.9% |
| FY2023 | -38.0% | +84.7% |
| FY2022 | -247.5% | +0.0% |
| FY2021 | -247.5% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026